Impact factor jama oncol
Witryna2374-2437 (print) 2374-2445 (web) Links. Journal homepage. Online access. Online archive. JAMA Oncology is a monthly peer-reviewed medical journal published by the American Medical Association. It covers all aspects of medical oncology, radiation oncology, and surgical oncology, as well as subspecialties. The journal was … WitrynaJAMA Oncol. 2024 Aug 15;5(11):1605-1613. doi: 10.1001/jamaoncol.2024.2109. Online ahead of print. ... Importance: To our knowledge, no randomized clinical trials have assessed the effects of the combination of weight loss and home-based exercise programs on lymphedema outcomes.
Impact factor jama oncol
Did you know?
WitrynaThe Journal Impact Factor is defined as all citations to the journal in the current JCR year to items published in the previous two years, divided by the total number of … WitrynaJAMA Oncology's acceptance rate is 11% for research articles. The median time to first decision is 1 day, and 33 days with review. All major articles are published online first. …
Witryna1 lis 2024 · Effect of Metformin Plus Tyrosine Kinase Inhibitors Compared With Tyrosine Kinase Inhibitors Alone in Patients With Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: A Phase 2 Randomized Clinical Trial ... JAMA Oncol. 2024 Nov 1;5(11):e192553. doi: 10.1001/jamaoncol.2024.2553. Epub 2024 Nov 14. Witryna1 paź 2024 · JAMA Oncol. 2024 Oct 1;5(10):1489-1496. doi: 10.1001/jamaoncol.2024.0620. Authors ... Observations: A higher proportion of premenopausal BCs occur in Asia, although this factor is possibly an age-cohort effect. Although the relative frequencies of different immunohistochemical subtypes of BC …
WitrynaThe journal’s impact factor of 31.8 placed us as one of the highest-ranking oncology journals. Choosing the best articles for the journal was rewarding but challenging. We … WitrynaUnadjusted and Adjusted effect for the tumor for DFS, OS and SAR in the molecular subgroups population ... with or without cetuximab: a post hoc analysis of the PETACC-8 trial. [Published online January 14, 2016]. JAMA Oncol. doi:10.1001/jamaoncol ... Primary Tumor Location and RAS/BRAF Mutational Status as Prognostic Factor in …
Witryna9 lis 2024 · Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. ... or orchiectomy. 2 While, consideration of the adverse effects associated with each of these therapies is a recommended consideration, ... JAMA …
WitrynaThe journal’s impact factor of 24.8 places it as one of the highest-ranking oncology journals. Evaluating and selecting the best manuscripts for publication in the journal … irr atccWitryna24 mar 2024 · Impact factor 3.467 (2024) Five year impact factor 23 days Submission to first decision (Median) 335,089 (2024) Downloads. Latest issue. Volume 28. Issue 4, April 2024 View all volumes and issues. Latest articles. The clinical impacts of postoperative complications after colon cancer surgery for the clinical course of … irr bot lawWitryna1 sie 2024 · JAMA Oncol. 2024 Aug 1;6(8):1210-1217. doi: ... These findings suggest that the total volume of sedentary behavior is a potential cancer mortality risk factor and support the public health message that adults should sit less and move more to promote longevity. MeSH terms portable bleacher seatsWitrynaJAMA Oncology is a monthly peer-reviewed medical journal published by the American Medical Association. It covers all aspects of medical oncology, radiation oncology, … portable bleacher rentals texasWitrynaAnnals of Oncology, the journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology, provides rapid and efficient peer-review … portable blender not chargingWitryna11 kwi 2024 · 《Journal of Oncology》发布于爱科学网,并永久归类相关SCI期刊导航类别中,本站只是硬性分析 "《J ONCOL》" 杂志的可信度。学术期刊真正的价值在于它是否能为科技进步及社会发展带来积极促进作用。"《J ONCOL》" 的价值还取决于各种因素的 … irr bursary 2022WitrynaJCO is one of the most prestigious oncology journals in the world, with an Impact Factor of 50.717, placing it among the top 1% of all journals, and with an Eigenfactor of 0.24903, which is the highest among oncology publications. In addition, JCO has the highest h-index among oncology journals reported by Google Scholar Metrics. irr best practices